# GlycoMimetics

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/glycomimetics

- Industry: Pharmaceuticals
- Headquarters: Gaithersburg, US
- Website: www.glycomimetics.com
- Total disclosed funding: $62M
- Latest round: Series C (Oct 20, 2009)
- Investors on record: 7

## About

Founded in 2003, GlycoMimetics is based in the US and operates as a bio-pharmaceutical company engaging in developing small molecule drugs.

## Funding rounds

- Series C, Oct 20, 2009, $38M — New Enterprise Associates, Novartis Venture Fund, Anthem Capital, PTV Healthcare Capital, Alliance Technology Ventures, Sanofi Ventures
- Series B, Jun 23, 2006, $15M — New Enterprise Associates, Novartis Venture Fund, Anthem Capital, PTV Healthcare Capital, Alliance Technology Ventures, Maryland Department of Business and Economic Development
- Series A, Aug 5, 2004, $5.1M — New Enterprise Associates, Novartis Venture Fund, Anthem Capital, PTV Healthcare Capital, Alliance Technology Ventures, Maryland Department of Business and Economic Development
- Series A, May 23, 2003, $4.3M — New Enterprise Associates, Novartis Venture Fund, Anthem Capital, Alliance Technology Ventures

## Investors

- New Enterprise Associates (https://capitalatlas.ai/funds/new-enterprise-associates) — Series A, Series B, Series C
- Novartis Venture Fund (https://capitalatlas.ai/funds/novartis-venture-fund) — Series A, Series B, Series C
- Anthem Capital (https://capitalatlas.ai/funds/anthem-capital) — Series A, Series B, Series C
- Alliance Technology Ventures (https://capitalatlas.ai/funds/alliance-technology-ventures) — Series A, Series B, Series C
- PTV Healthcare Capital (https://capitalatlas.ai/funds/ptv-healthcare-capital) — Series A, Series B, Series C
- Maryland Department of Business and Economic Development — Series A, Series B
- Sanofi Ventures (https://capitalatlas.ai/funds/sanofi-ventures) — Series C